Core Insights - Oxford Industries reported revenue of $403.14 million for the quarter ended July 2025, reflecting a year-over-year decline of 4% [1] - The EPS for the same period was $1.26, down from $2.77 a year ago, with a surprise of +4.13% compared to the consensus estimate of $1.21 [1] - The revenue fell short of the Zacks Consensus Estimate of $407.65 million, resulting in a surprise of -1.11% [1] Financial Performance Metrics - Net Sales for Emerging Brands reached $38.5 million, exceeding the two-analyst average estimate of $33.95 million, representing a year-over-year increase of +17% [4] - Net Sales for Lilly Pulitzer were reported at $90.3 million, below the average estimate of $98.15 million, indicating a year-over-year decline of -1.5% [4] - Net Sales for Tommy Bahama stood at $229 million, slightly below the estimated $229.15 million, reflecting a year-over-year decrease of -6.6% [4] - Net Sales for Johnny Was were $45.4 million, compared to the average estimate of $46.55 million, showing a year-over-year decline of -9.7% [4] Stock Performance - Shares of Oxford Industries have returned -5.8% over the past month, contrasting with the Zacks S&P 500 composite's +2.1% change [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]
Oxford Industries (OXM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates